EXAS vs NFLX · rev $2.76B vs P/E 25, rev $12.56B
EXACT Sciences Corporation (EXAS) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
EXAS currently screens at market cap $20.03B. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the EXAS and NFLX stock pages for the full models.
Not investment advice.